Skip to main content
. 2021 Jan 25;14:227–236. doi: 10.2147/IDR.S293290

Table 1.

Genetic and Phenotypic Traits of MDR Klebsiella pneumoniae Isolates

Total n=200 (%) MDR n=125 (%) Non-MDR n=75 (%) MDR ESBLs n=42 (%) MDR CRKP n=72 (%) MDR HMV n=30 (%)
Specimen source
Blood 31 (16) 21 (17) 10 (13) 9 (21) 13 (18) 3 (10)
Urine 86 (43) 47 (38) 39 (52) 15 (36) 15 (21) 18 (60)
Pus 41 (21) 28 (22) 13 (17) 8 (19) 20 (28) 5 (17)
Catheter tip 9 (5) 8 (6) 1 (1) 4 (10) 5 (7) 1 (3)
Body fluid 16 (8) 12 (10) 4 (5) 2 (5) 10 (14) 2 (7)
Bile 2 (1) 2 (2) 0 (0) 0 (0) 2 (3) 1 (3)
Nasal/Tracheal swab 8 (4) 6 (5) 2 (3) 3 (7) 6 (8) 0 (0)
Sputum 5(3) 0 (0) 5 (7) 0 (0) 0 (0) 0 (0)
Tissue 2(1) 1 (1) 1 (1) 1 (2) 1 (1) 0 (0)
Genetic determinants for:
ESBLs
*blaTEM 60 (30) 47 (38) 13 (17) 34 (81) 23 (32) 19 (63)
*blaSHV 69 (35) 49 (39) 20 (27) 32 (76) 24 (33) 24 (80)
*blaCTXM-14 30 (15) 26 (21) 4 (5) 14 (33) 12 (17) 14 (47)
*blaCTXM-15 91 (46) 67 (54) 24 (32) 36 (86) 32 (44) 29 (97)
*blaOXA 39 (20) 34 (27) 5 (7) 21 (50) 15 (21) 13 (43)
Carbapenemases
blaNDM-1 78 (39) 69 (55) 9 (12) 22 (52) 52 (72) 26 (87)
blaKPC 9 (5) 7 (6) 2 (3) 4 (10) 7 (10) 1(3)
blaOXA 48 type 48(24) 40 (32) 8 (11) 11 (26) 30 (42) 16 (53)
Colistin resistance
mcr-1 24 (12) 19 (15) 5 (7) 7 (17) 11 (15) 6 (20)
mcr-2 17 (9) 13 (10) 4 (5) 4 (10) 7 (10) 5 (17)
Efflux pumps
acrAB 97 (49) 62 (50) 35 (47) 25 (60) 31 (43) 20 (67)
tolC 62 (31) 48 (38) 14 (19) 20 (48) 24 (33) 13 (43)
Porins
ompK35 111 (56) 75 (60) 36 (48) 29 (69) 44 (61) 17 (57)
ompK36 110 (55) 65 (52) 45 (60) 20 (48) 35 (49) 11 (37)
Virulence factors
*rmpA 21(11) 16 (13) 5 (7) 6 (14) 7 (10) 16 (53)
iucA 16 (8) 13 (10) 3 (4) 7 (16) 6 (8) 7 (23)
Kfu 6 (3) 4 (3) 2 (3) 0 (0) 1 (1) 3 (10)
Bss 31 (16) 23 (18) 8 (11) 10 (24) 10 (14) 12 (40)
fimH 38 (19) 28 (22) 10 (13) 10 (24) 20 (28) 12 (40)
mrkD 35 (18) 21 (17) 14 (19) 8 (19) 18 (25) 9 (30)
ycfM 43 (22) 26 (21) 17 (23) 7 (17) 14 (19) 4 (13)
traT 7 (4) 5 (4) 2 (3) 1 (2) 3 (4) 1 (3)
Virulence phenotypes
Capsule 198 (99) 123 (98) 75 (100) 42 (100) 70 (97) 30 (100)
Gelatinase 24 (12) 19 (15) 5 (7) 6 (14) 7 (10) 6 (20)
Blood hemolysis 15 (8) 10 (8) 5 (7) 2 (5) 3 (4) 3 (10)
Biofilm potential 187(94) 118 (94) 69 (92) 42 (100) 68 (94) 30 (100)
Haemagglutination 200(100) 125 (100) 75 (100) 42(100) 72(100) 30(100)
Hypermucoviscosity 43 (22) 30 (24) 13 (17) 12 (29) 15 (21) 30 (100)

Notes: Numbers (and percentage with respect to value in the first row of the corresponding column) of MDR isolates displaying the corresponding phenotype or genetic locus are shown. All MDR strains are included in this category (including strains with ESBL, CRKP and HMV phenotypes). A significant p-value indicates strong association of a factor within the four population subgroups (MDR, MDR ESBLs, MDR CRKP and MDR HMV). The significant p-value of association calculated for ESBL factors (blaTEM, blaSHV, blaCTXM-14, blaCTXM-15) within the four population groups: MDR, MDR ESBLs, MDR CRKP and MDR HMV was found to be <0.00001*; for blaOXA the significant value was 0.003541*. 1Beta-lactamase genes (blaTEM, blaSHV, blaCTXM-14, blaCTXM-15, blaOXA); carbapenemase determinants: (blaNDM-1, blaKPC, blaOXA48-type); colistin resistance genes :(mcr-1, mcr-2); efflux pump genes: (acrAB, tolC) porin genes: (ompK35, ompK36) virulence determinants: (rmpA iucA, Kfu, Bss, fimH, mrkD ycfM, traT).

Abbreviations: MDR, multidrug-resistant; ESBL, extended spectrum beta-lactamase; CRKP, carbapenem resistant Klebsiella pneumoniae; HMV, Hypermucoviscous; MDR ESBLs, multidrug-resistant extended spectrum beta-lactamase; MDR CRKP, multidrug-mesistant carbapenem resistant Klebsiella pneumoniae; MDR HMV, multidrug-resistant hypermucoviscous.